Close Menu

NEW YORK (GenomeWeb) – Food safety testing firm Sample6 announced yesterday that it has raised $12.5 million in a Series C financing round, bringing the total of various investments in the company to date to $32 million.

The latest financing round was led by Acre Venture Partners, and included Valley Oak Investments, Caanan Partners, and Cultivian Sandbox Ventures.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.